Crabtree & Evelyn files for chapter 11
This article was originally published in The Rose Sheet
Executive Summary
Connecticut-based soap and personal-care maker Crabtree & Evelyn files for bankruptcy protection. Company will undergo a reorganization to "capitalize on opportunities for future growth and profitability," which will include strengthening brand strategies, restructuring its financial obligations and evaluating its real-estate portfolio, according to July 1 release. Meanwhile business operations will continue through firm's wholesale, e-commerce and retail operations. Members of the Crabtree & Evelyn group, which includes affiliates in Canada, European Union, Hong Kong, Malaysia, Singapore and Australia, have not filed for protection
You may also be interested in...
Out Of Bankruptcy, Crabtree & Evelyn Emphasizes Consumer Relationships
Embracing its "fresh start," Crabtree & Evelyn is focused on positioning its brand and engaging consumers this year as it emerges from bankruptcy in the U.S
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.